期刊文献+

保肝宁对肝星状细胞中核转录因子-κB活性影响的实验研究 被引量:2

Experimental Study on Effect of Baoganning on Activity of Nuclear Transcription Factor-κB in Hepatic Stellate Cells
下载PDF
导出
摘要 目的观察中药复方保肝宁对肝星状细胞(hepaticstellatecell,HSC)中核转录因子κB(nuclearfactorκB,NFκB)活性的影响及其相关机制。方法给正常Wistar大鼠灌胃保肝宁煎剂7天,制备含药血清,用MTT法检测其对肝星状细胞HSCT6生长的影响,用蛋白印迹实验(Westernblottinganalysis)检测药物作用不同时间NFκB蛋白抑制因子IκB磷酸化水平,用凝胶阻滞实验(gelshiftassay)检测药物作用30min后NFκB与DNA的结合水平。结果中药复方保肝宁对HSCT6细胞生长有显著的抑制作用;可快速抑制IκB磷酸化,30min达到最高水平,6h恢复至基础水平;可改变NFκB与DNA结合水平,使其与DNA结合能力下降。结论中药复方保肝宁能抑制IκB磷酸化,降低NFκB活性,并改变NFκB与DNA的结合水平。 Objective To investigate the effect of Baoganning (BGN) on activity of nuclear transcription factor-κB (NF-κB) in hepatic stellate cells (HSCs) and its relevant mechanisms. Methods Normal Wlstar rats were medicated with BGN decoction by garage for 7 days to prepare BGN drug-serum. The effect of BGN drugserum on HSC-T6 growth was measured by MTT assay; phosphorylation level of NF-κB inhibiting factor IκB at different time after BGN stimulation was detected by Western blotting analysis; and the binding level of NF-κB with DNA was measured 30 min after drug-serum stimulation with gel shift assay, Results BGN could significantly inhibit the HSC-T6 growth and quickly supress the phosphorylation of IκB, with the effect reached its peak at 30 min and restored to baseline level 6 h after stimulation, and reduce the binding capacity of NF-κB with DNA, Conclusion BGN can inhibit phosphorylation of IκB, restrain the activity of NF-κB and change the binding level of NF-κB with DNA.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2005年第9期804-807,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家自然科学基金资助课题(No.30271627) 广东省自然科学基金资助课题(No.020337)
  • 相关文献

参考文献9

  • 1赵进军,吕志平,张绪富.保肝宁抗大鼠肝纤维化的作用[J].中国中西医结合杂志,2002,22(S1):158-161. 被引量:7
  • 2张绪富,吕志平,周迎春,赵进军,刘晓燕.保肝宁对HSC-T_6细胞增殖及Ⅰ型胶原表达的影响[J].中医药学刊,2003,21(2):207-208. 被引量:19
  • 3王宁生.关于血清药理学的若干思考[J].中国中西医结合杂志,1999,19(5):263-263.
  • 4Son G,Iimuro Y,Ogushi H,et al.Transcription factor dedoy for NF-kappa B inhibits CCl4-induced liver injury and fibrosis in mice.Hepatology 2002;36(4)Pt2:245A.
  • 5Karin M,Ben-Neriah Y.Phosphorylation meets ubiquitination:the control of NF-kappa B activity.Annu Rev Immunol 2000;18(1):621-663.
  • 6Chen F,Castranova V,Shi X,et al.New insights into the role of nuclear factor-κ B,a ubiquitous transcription factor in the initiation of diseases.Clin Chem 1999;45(1):7-17.
  • 7Friedman SL.Molecular regulation of hepatic fibrosis,an integrated cellular response to tissue injury.J Biol Chem 2000;275(4):2247-2250.
  • 8van den Berg R,Haenen GR,van den Berg H,et al.Transcription factor NF-kappa B as a potential biomarker for oxidative stress.Br J Nutr 2001;86(Suppl 1):S121-127.
  • 9Joyce D,Albanese C,Steer J,et al.NF-kappa B and cell-cycle regulation:the cyclin connection.Cytokine Growth Factor Rev 2001;12(1):73-90.

二级参考文献4

共引文献109

同被引文献138

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部